Pfizer (OSTO:PFE) Forward Dividend Yield % : 3.93% (As of Apr. 26, 2024)

View and export this data going back to 2003. Start your Free Trial

What is Pfizer Forward Dividend Yield %?

As of today (2024-04-26), the Forward Annual Dividend Yield of Pfizer is 3.93%.

As of today (2024-04-26), the Trailing Annual Dividend Yield of Pfizer is 3.88%.

OSTO:PFE's Forward Dividend Yield % is ranked better than
94.76% of 496 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs OSTO:PFE: 3.93

Pfizer's Dividends per Share for the three months ended in Dec. 2023 was kr0.00.

During the past 12 months, Pfizer's average Dividends Per Share Growth Rate was 2.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 2.60% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 3.70% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 5.60% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Pfizer was 22.60% per year. The lowest was -14.70% per year. And the median was 10.20% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Pfizer's Forward Dividend Yield %

For the Drug Manufacturers - General subindustry, Pfizer's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pfizer's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Pfizer's Forward Dividend Yield % falls into.

Pfizer Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Pfizer (OSTO:PFE) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Pfizer Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Pfizer's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (OSTO:PFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (OSTO:PFE) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Austria PFE:Argentina

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.